Contract Research Organization WCCT Global to Attend the 2014 DIA Meeting
WCCT Global to Attend the 2014 DIA Meeting in San Diego
COSTA MESA, Calif., June 12, 2014 /PRNewswire-iReach/ — WCCT Global (WCCTG), a Southern California headquartered Full Service Contract Research Organization announced today that the organization will be attending the 2014 DIA meeting in San Diego, California. WCCT Global will be an exhibitor at booth #821. WCCTG will be sharing information about many of the exciting clinical research services the company has both added and grown since DIA 2013. One of the areas that WCCTG will be discussing is their newest research facility which was designed specifically for influenza challenge clinical trials. The WCCT Global, Costa Mesa Clinical Pharmacology Unit (CPU) is the only commercial influenza challenge unit in the United States. Other areas of discussion include their clinical research capabilities in Phase I thru IV clinical development, focusing on the WCCTG California -based CPUs dedicated to phase I clinical trials requiring either short or long confinement periods and their full-service capabilities to manage large multi-center trials. WCCT Global stated their focus the previous year was to continue to build unique infrastructure and add resources so they would be able to offer diverse clinical research services to all clients in order to differentiate themselves. Many new strategic acquisitions and hiring of key personnel with specialized research skills has positioned WCCT Global to be a unique service provider for early and late phase clinical development programs.
At this year’s DIA event, many key members from WCCT Global will be in attendance, including Dr. Kenneth Kim, CEO and Mr. Jon Rojas, COO. They will be available to discuss where the company is headed and review the exciting changes within the organization. WCCT Global’s COO Jon Rojas stated,
“We are pleased to be attending the 2014 DIA meeting in San Diego and for the opportunity to share the exciting new and enhanced clinical trial services our company has added since the last year’s DIA meeting. We will be discussing our new ideas for Asian bridging trials, Influenza challenge strategies and our exciting patient recruitment technology.”
The contract clinical research industry is in a constant state of change and innovation is the key to success. WCCT Global is leading in many areas of clinical research with innovations and development to ultimately make clinical research as efficient and scientifically sounds as possible. For more information about key capabilities of WCCT Global, stop by booth #821.
More about WCCT Global
WCCT Global is a multi-site, full service pharmaceutical contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
For request information about WCCT Global can be of assistance to your upcoming clinical trial, CLICK HERE
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global